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Aggregation and secretion of washed platelets from stroke-prone spontaneously hypertensive rats (SHRSP) 
were greatly reduced by the development of the hypertension compared with those of platelets from age- 
matched normotensive Wistar-Kyoto rats (WILY). Concomitantly, thrombin-induced phosphorylation of 
the 47 kDa protein in SHRSP platelets was significantly decreased. However, TPA-induced aggregation, 
secretion and 47 kDa protein phosphorylation in SHRSP platelets were similar to those in WKY platelets. 
These results suggest hat protein kinase C activity and its substrate were normally present in SHRSP plate- 
lets and that defects in the receptor-mediated activation of protein kinase C. This defective protein phos- 
phorylation may be an underlying mechanism for the dysfunction of SHRSP platelets. 
(Stroke-prone spontaneously hypertensive rat) Platelet aggregation 12-O-Tetradecanoylphorbol-13-acetate 
Serotonin Secretion Protein phosphorylation 
1. INTRODUCTION 
We have shown that thrombin-, collagen-, ADP- 
and ionophore A23 18%induced aggregation, as 
well as thrombin-induced serotonin release, in 
washed platelets from SHRSP were greatly re- 
duced with the development of hypertension com- 
pared with those of platelets from age-matched 
normotensive WKY fl,2]. To clarify the 
mechanism for dysfunctions in SHRSP platelets, 
we examined platelet-protein phosphorylation 
which played an important role in stimulus- 
response coupling [3]. 
In human platelets stimulated with thrombin or 
other physiologic~ stimuli, there was a rapid and 
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hypertensive rats; WKY, Wistar-Kyoto rats; TPA, 12-O- 
tetrad~noylphor~l Ifacetate; [Ca’+fi, cytoplasmic 
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transient rise in 1 ,Zdiacylglycerol and intracellular 
Ca’+ concentration. On the other hand, two en- 
dogenous proteins with appro~mate mol~ul~ 
masses of 47 kDa and 20 kDa are rapidly and 
heavily phosphorylated in parallel with 
physiological responses [3]. The phosphorylation 
of 20 kDa protein (myosin light chain) is 
calmodulin dependent and requires mobilization 
of Ca2+. The 47 kDa protein is phospho~lated by 
phospholipid-dependent and Ca’+-activated pro- 
tein kinase (protein kinase C), its activation is 
associated with the transient appearance of diacyl- 
glycerol in the membrane. Diacylglycerol produced 
by the receptor-activated hydrolysis of phos- 
phatidylinositol, acts as a signal molecule by 
enhancing the Ca2+ sensitivity of protein kinase C. 
Several phorbol esters such as TPA (a potent 
tumor promotor) directly activate protein kinase C 
by increasing the affinity for Ca’+. 
Here it is demonstrated that thrombin-induct 
protein phospho~lation (47 kDa) was significant- 
ly decreased in SWRSP platelets which showed 
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hypoaggregation and reduced secretory responses. 
Similar abnormalities of platelets in a patient have 
been cited as a new congenital defect of platelets by 
Hard&y et al. 141. 
2. MATERIALS AND METHODS 
f’4C]Serotonin (58.5 mCi/mmoI) was from NEN 
(Boston, MA) and [32P]orthophosp~te (carrier 
free) from Japan Isotope (Tokyo), ionophore 
A23187 from Calbiochem (La Jolla, CA), TPA 
from Sigma (St. Louis, MO) and thrombin from 
Midori Cross (Osaka). 
SHRSP and WKY, maintained by brother-sister 
breeding, were killed at 11-14 weeks old. Washed 
platelets were prepared according to Baenziger and 
Majerus [5] or Feinstein et al. [6]. 
Platelet aggregation was measured by the tur- 
bidometric method described in [7]. 
2.?. Assay o~f*‘~~~eroro~in release 
The assay was performed by a m~i~~ation of 
the methods of Hofmann et al. f8] and Holmsen et 
al. IS]. [‘“CJSerotonin prelabelled platelets in 
resuspending buffer [5] (4x IO* cells/ml) were in- 
cubated with thrombin at 37OC in the presence of 
1.5 mM Ca2+. The percentage of release of 
f’%Z]serotonin was calculated according to the 
following equation: release (To) = (St-Sc)/(T-Sc) 
[T; total radioactivity in the whole mixture, St and 
SC; radioactivity in the supernatant with and 
without thrombin]. 
2-4. Analysis o~~~a~~e~-pr~~~~~ ho ~hory~a~~o~ 
“P-prelabefled platelets (0.2 ml) which were 
prepared according to F&stein et al. [6] and 
suspended in 25 mM Tris-HCl buffer containing 
137 mM NaCl, 5.4 mM KCI, 0.2% dextrose, 
pH 7.4, to make 5 x lo* cells/ml, were incubated 
with CaClz (tO$, final ~~n~~n~ation 1.5 ml@) 
and aggregating agents @O/11) while stirring at 
37°C. The reaction was terminated by adding a 
SDS stopping solution (9% SDS, 6% mercapto- 
ethanol, 15% glycerol, 186 mM Tris-HCl, pH 6.8, 
with a small amount of bromphenol blue) and then 
140 
the mixture was boiled for 2 min. The protein was 
subjected to SDS-polyacrylamide gel elec- 
trophoresis by the method of Laemmli [lo] and 32P 
content of the protein bands were analyzed by den- 
sitometry of autoradiographs (Chromoscan 200, 
Joiee Loebie, Gateshead, England), Results are ex- 
pressed as relative protein phosphorylation to 
phosphorylation observed in unstimulated condi- 
tion. 
3. RESULTS 
3.1. Thrombin-induced aggregation and 
[‘4C]serotonin release 
When platelets from SHRSP at hypertensive 
ages and age-matched WKY were stimulated with 
thrombin, SHRSP platelets aggregated and re- 
leased [r4C]serotonin at a significantly reduced rate 
compared with WKY platelets as shown in fig.1 I 
Hypoaggregation and reduction of [r4C]serotonin 
release in SHRSP platelets were observed at all the 
concentrations examined (fig.Ib and d). Aggrega- 
tion was affected more than the release in SHRSP 
platelets. 
3.2. Protein ~h~~phory~~f~on by ~brombin 
Since aggregation as well as secretion paralleled 
with protein phospho~lation ] I 1 J ) thrombin- 
induced protein phosphorylation was examined, 
32P-prelabelled platelets from SHRSP and WKY 
were incubated at various times with 0.15 U/ml 
thrombin and the protein was subjected to SDS- 
PAGE, Gels were stained with Coomassie brilliant 
blue R and the dried gels were analyzed by auto- 
radiography. In the autoradiogram the band of 
47 kDa protein was barely visible in the sample in- 
cubated without thrombin, while dark bands ap- 
peared when incubated with thrombin, The bands 
of SHRSP platelets were lighter than those of 
WKY platelets. In contrast, the 20 kDa protein 
bands were already observed in unstimulated 
samples and became slightly darker in the 
stimulated samples. Fig.2 shows the time courses 
and con~entration~ependency urves of phos- 
phorylation of the 47 kDa proteins of SHRSP and 
WKY platelets by thrombin. 
When 32P-prelabelled platelets were incubated 
with 0.15 U/ml thrombin, phosphorylation of 
protein occurred instantly and reached a maximum 
at 30 s, Compared with WKY platelets, there was 
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Fig.1. Time courses and concentration-dependency urves of thrombin-induced aggregation (a,b) and [r4C]serotonin 
release (c,d) in platelets from SHRSP (-o-) and WKY (- - o - -). Washed platelets (4 x lo* cells/ml) were stimulated 
with thrombin (0.22 U/ml in a, 0.30 U/ml in c) for 3 min in b and d. Results are expressed as mean f SD for the 
number of platelet preparations (n = 5 in b, n = 3 in c, n = 4 in d). + Significance P< 0.001. 
a marked decrease in phosphorylation of the 
47 kDa protein in SHRSP platelets. The phos- 
phorylation of the 20 kDa protein was similar in 
the platelets from the two strains. The 47 kDa pro- 
tein was dose-dependently phosphorylated up to 
0.4 U thrombin/ml in SHRSP platelets. The phos- 
phorylation was a maximum at 0.2 U thrombin/ml 
in WKY platelets. Simultaneous measurement of 
aggregation in a 32P-prelabelled platelet prepara- 
tion showed significantly attenuated responses in 
SHRSP platelets compared with those in WKY 
platelets (see fig.2, legend). 
3.3 Effects of TPA on protein kinase C 
Since there was a marked decrease in thrombin- 
induced phosphorylation of the 47 kDa protein of 
SHRSP platelets the effects of TPA, a direct ac- 
tivator of protein kinase C, were examined (fig.3). 
TPA at concentrations less than 20 nM did not in- 
duce aggregation (fig.3a) or [14C]serotonin secre- 
tion (not shown), while at the higher concentra- 
tions, aggregation was induced slowly with time as 
shown in fig.3b. In contrast to thrombin stimula- 
tion, the aggregation response to TPA (80 nM) 
was similar in.SHRSP and WKY platelets. Fig.3c 
and d depicts the effect of TPA on 47 kDa protein 
phosphorylation. The TPA effect on phos- 
phorylation was seen at a concentration as low as 
0.5 nM and it peaked at 30 s-l min. Again there 
was no difference in the magnitude of 47 kDa pro- 
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Fig.2. Time courses (a) and concentration-dependency curves (b) of thrombin-induced protein phosphorylation in 
platelets from SHRSP (-o--) and WKY (--o- -). 32P-prelabelled platelets in 25 mM Tris-HCI buffer (pH 7.4) were 
stimulated with thrombin (0.15 U/ml in a) for 3 min in b. Phosphorylated protein was analyzed by autoradiography 
as described in section 2. Results are expressed as mean f SD in a (n = 4) and mean of duplicates in b. Aggregation 
responses simultaneously measured with the 32P-prelabelled platelets are: a, 31% in SHRSP and 73& in WKY; b, 
(thrombin 0.11 U/ml) 9% in SHRSP and 33% in WKY, (thrombin 0.22 U/ml) 59% in SHRSP and 82% in WKY, 
(thrombin 0.44 U/ml) 86% in SHRSP and 89% in WKY. * Significance PC 0.05. 
tein phosphorylation between platelets from the 
two strains. These results suggest hat the activity 
of protein kinase C and the amount of the 
substrate protein (47 kDa) were comparable in 
SHRSP and WKY platelets, but the receptor- 
mediated activation of protein kinase C seems to 
be impaired in SHRSP platelets. 
4. DISCUSSION 
We found in this study that thrombin-induced 
phosphorylation of the 47 kDa protein was 
significantly reduced in SHRSP platelets accompa- 
nying hypoaggregation and reduced serotonin 
release. The phosphorylation of the protein, 
however, was comparable to that in WKY platelets 
when stimulated with TPA which activated protein 
kinase C directly in vivo and in vitro. The possibili- 
ty that a reduction in protein phosphorylation 
might result from a reduced production of [32P]- 
ATP in SHRSP platelets would be excluded by the 
fact that TPA-induced phosphorylation of the 
47 kDa protein was similar in platelets from the 
two strains; there was no difference in thrombin- 
induced phosphorylation of the 20 kDa protein. 
The defective phosphorylation of the 47 kDa pro- 
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Ag.3. Concentration~e~ndency curves and time courses of TPA-induced a~reg&tion (a,b) and 47 kDa protein 
phosphorylation (c,d) in platelets from SHRSP f--+-) and WKY (- -o- -). 3ZP-prelabelled platelets in 25 mM Tris-HCI 
buffer (pH 7.4) were stimulated with TPA for 5 min in a and 1 min in c. Each point represents mean of triplicates. 
tein may be influenced by an impairment of 
receptor-mediated formation of intracellular 
signals such as diacylglycerol and Ca2+ or an im- 
pairment in activation of protein kinase C by these 
activators. Since decreased responses in SHRSP 
platelets were observed with several stimuli other 
than thrombin, defects will not be in specific recep- 
tors. Therefore, it is of interest to note that 
thrombin-induced increase in [Ca*+fi, measured by 
using quin 2, was delayed in SHRSP platelets; the 
time to peak was twice as long as in SHRSP 
platelets. Thrombin-induced uptake of 45Ca2+ was 
also delayed in SHRSP platelets [ 131. Additional- 
ly, the content of phosphatidyl~ositol in SHRSP 
platelets was lower than in WKY platelets. The 
contents in the erythrocytes from SHR are 
reportedly changed [ 141. 
Phosphatidylinositol and phosphatidylinositol 
phosphates play a central role in stimulus-response 
coupling 13, IS]. It remains to be explored how the 
decrease in phosphatidylinositol content of 
SHRSP platelets influences signal transduction 
and how the delay of thrombin-induced [Ca’+]i in- 
crease is associated with defective protein phos- 
phorylation and consequent physiological re- 
sponses. This study will contribute towards 
understanding a link of defective phosphorylation 
of platelet protein to genetic dysfunction of 
platelets. 
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